Showing results (31-40 of 77) with videos related to
Sort By:
Pageof 8
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|March 1, 2024
Genetic insights into the gut microbiota and risk of facial skin aging: A Mendelian randomization studyMulan Chen, Yuhui Che, Mengsong Liu, et al.Nanoscale|May 2, 2023
Near-infrared light-controlled kartogenin delivery of multifunctional Prussian blue nanocomposites for cartilage defect repairZunhan Liu, Zhenyu Luo, Haoda Yu, et al.Journal of Neuro-Oncology|September 3, 2021
Cytoskeleton-associated protein 4 (CKAP4) promotes malignant progression of human gliomas through inhibition of the Hippo signaling pathwayTao Luo, Kaikai Ding, Jianxiong Ji, et al.Heliyon|September 19, 2024
Natural products for the treatment of hypertrophic scars: Preclinical and clinical studiesYuxiao Zhang, E Liu, Hongjin Gao, et al.Frontiers in Pharmacology|June 3, 2022
Resibufogenin Targets the ATP1A1 Signaling Cascade to Induce G2/M Phase Arrest and Inhibit Invasion in GliomaXun Zhang, Zhong Yao, Zhiyi Xue, et al.Acta Biomaterialia|May 22, 2017
Composite elastomeric polyurethane scaffolds incorporating small intestinal submucosa for soft tissue engineeringLincui Da, Mei Gong, Anjing Chen, et al.Molecular Neurobiology|January 16, 2015
Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-AnalysisMingzhi Han, Laixiu Guo, Ya Zhang, et al.The Journal of Arthroplasty|June 20, 2025
Effects of Single or Repeated Doses of Dexamethasone on Postoperative Glycemia in Patients Who Have Diabetes Mellitus After Primary Total Joint Arthroplasty: A Randomized Controlled TrialHaiwei Tang, Ping Mou, Xiaoyang Liu, et al.Cancer Letters|April 6, 2024
Targeting the molecular chaperone CCT2 inhibits GBM progression by influencing KRAS stabilityFeihu Zhao, Zhong Yao, Yaquan Li, et al.Cell Death and Differentiation|August 21, 2020
TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBαJianxiong Ji, Kaikai Ding, Tao Luo, et al.Pageof 8